X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
humans (8) 8
mds (8) 8
myelodysplastic syndromes (7) 7
hematology (6) 6
prognosis (6) 6
aged (5) 5
aged, 80 and over (5) 5
female (5) 5
male (5) 5
middle aged (5) 5
myelodysplastic syndromes - genetics (5) 5
oncology (5) 5
analysis (4) 4
hemic and lymphatic diseases (4) 4
scoring system (4) 4
acute myeloid-leukemia (3) 3
adult (3) 3
apoptosis (3) 3
azacitidine (3) 3
azacitidine - therapeutic use (3) 3
bone-marrow (3) 3
cancer (3) 3
in situ hybridization, fluorescence - methods (3) 3
karyotype (3) 3
leukemia (3) 3
myelodysplastic syndromes - drug therapy (3) 3
myelodysplastic syndromes - mortality (3) 3
prospective studies (3) 3
treatment outcome (3) 3
adolescent (2) 2
aml (2) 2
antigens, cd34 - blood (2) 2
articles (2) 2
azacitidine - administration & dosage (2) 2
bcl-2 family (2) 2
cell line, tumor (2) 2
chemotherapy (2) 2
chromosomal-abnormalities (2) 2
chromosome deletion (2) 2
cytogenetics (2) 2
fish (2) 2
follow-up studies (2) 2
gene expression (2) 2
genetics & heredity (2) 2
germany (2) 2
hematology, oncology and palliative medicine (2) 2
lenalidomide (2) 2
leukemia, myeloid, acute - drug therapy (2) 2
leukemia, myeloid, acute - etiology (2) 2
leukemia, myeloid, acute - genetics (2) 2
leukemia, myeloid, acute - mortality (2) 2
myelodysplastic syndrome (2) 2
myelodysplastic syndromes - complications (2) 2
retrospective studies (2) 2
situ hybridization analysis (2) 2
stem (2) 2
survival rate (2) 2
thalidomide - analogs & derivatives (2) 2
thalidomide - therapeutic use (2) 2
young adult (2) 2
5-azacitidine (1) 1
5-azacytidine (1) 1
abnormalities (1) 1
abt-199 (1) 1
acute myelogenous leukemia (1) 1
age (1) 1
alveolar epithelial-cells (1) 1
anemia - etiology (1) 1
anemia - therapy (1) 1
animals (1) 1
anomalies (1) 1
antigens, cd34 - genetics (1) 1
antigens, cd34 - metabolism (1) 1
antilymphocyte serum - therapeutic use (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis - physiology (1) 1
arsenic - therapeutic use (1) 1
association (1) 1
association between vitamin d and mds (1) 1
autophagy (1) 1
autophagy and cell death (1) 1
azacitidine - analogs & derivatives (1) 1
bacteria (1) 1
bone marrow (1) 1
brief communication (1) 1
case-control studies (1) 1
caspase (1) 1
caspases - metabolism (1) 1
cd34 (1) 1
chemokine receptor cxcr4 (1) 1
chromosomal aberrations (1) 1
chromosome 7 (1) 1
chromosome aberrations (1) 1
chromosome aberrations - drug effects (1) 1
chromosome banding (1) 1
chromosome banding - methods (1) 1
chromosomes (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Experimental hematology & oncology, ISSN 2162-3619, 2019, Volume 8, Issue 1, pp. 9 - 5
Patients with Myelodysplastic Syndromes (MDS) and secondary Acute Myeloid Leukemia (sAML) have a very poor prognosis after failure of hypomethylating agents... 
Usage | Prognosis | Stem cells | Transplantation | Research | Drug therapy | Myelodysplastic syndromes | Apoptosis | Flow cytometry | Chemotherapy | Medical prognosis | Leukemia | Bone marrow | Cytotoxicity | Age | Hematotoxicity | Combination therapy | MDS | HMA failure | Venetoclax
Journal Article
Oncotarget, ISSN 1949-2553, 04/2018, Volume 9, Issue 25, pp. 17270 - 17281
Somatic mutations in genes such as , , or adversely affect the outcome of patients with myelodysplastic syndromes (MDS). Since selective BCL-2 inhibition is a... 
BCL-2 family | Autophagy | ABT-199 | Myelodysplastic syndromes | Myeloid malignancy | Apoptosis
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4297 - 4297
Abstract Introduction: Myelodysplastic syndromes (MDS) are one of the most common haematological disorders of the older patient. Allogeneic stem cell... 
Journal Article
Haematologica, ISSN 0390-6078, 2015, Volume 100, Issue 2, pp. 205 - 213
Journal Article
European Journal of Haematology, ISSN 0902-4441, 11/2019
INTRODUCTIONTargeting the cell cycle machinery represents a rational therapeutic approach in Myelodysplastic Syndromes (MDS) and secondary Acute Myeloid... 
Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 14, pp. 1591 - 1597
Journal Article
Leukemia Research, ISSN 0145-2126, 2013, Volume 37, Issue 8, pp. 900 - 906
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1275 - 1275
Abstract Introduction AML is an aggressive hematological neoplasm originating from hematopoietic precursor or stem cells and is rapidly fatal if untreated.... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 2797 - 2797
Abstract Introduction Higher-risk myelodysplastic syndromes (MDS) progress to secondary acute myeloid leukemia (sAML) within months. Treatment with azacitidine... 
Journal Article
Acta Haematologica, ISSN 0001-5792, 05/2019, Volume 141, Issue 4, pp. 225 - 231
Background/Aims: There is growing evidence supporting the role of innate immune deregulation and inflammation in the pathogenesis of myelodysplastic syndromes... 
Brief Communication | INFECTIONS | PREVENTION | INNATE IMMUNE | Association between vitamin D and MDS | CANCER | Myelodysplastic syndromes | STEM | Serum vitamin D level | SCORING SYSTEM | MUTATIONS | HEMATOLOGY | ASSOCIATION | MDS
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 2784 - 2784
Abstract Introduction Total (-7) or partial (7q-) monosomy 7 is frequent in malignant myeloid disorders, observed in around 12% of MDS/AML and up to 40% of... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.